Final height in girls with central precocious puberty: comparison of two different luteinizing hormone-releasing hormone agonist treatments. 1994

F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
Pediatric Endocrine Unit, University of Verona, Italy.

In order to evaluate the effects of two long-acting luteinizing hormone-releasing hormone agonists on growth, bone maturation and final height in girls with central precocious puberty, we analyzed growth data from 40 girls (15 treated with buserelin intranasal spray (group A), 15 treated with triptorelin depot im every 28 days (group B) and 10 untreated (group C)). Patients in group A started treatment when chronological age (CA) was 7.7 +/- 0.9 years, bone age (BA) was 10.2 +/- 1.1 years and height was 131.9 +/- 5.0 cm. Patients in group B started therapy when CA was 7.6 +/- 0.5 years, BA 9.8 +/- 1.0 years and height 133.2 +/- 7.6 cm. The diagnosis of untreated patients (group C) was made when CA was 7.2 +/- 0.9 years, BA 9.6 +/- 2.2 years and height 130.2 +/- 8.6 cm. Both luteinizing hormone-releasing hormone agonists appeared to control precocious puberty. Final height in group B (160.6 +/- 5.7 cm) was significantly higher than that of group A (153.2 +/- 5.0 cm: p < 0.05) and group C (149.6 +/- 6.3; p < 0.01), whereas the difference between groups A and C was not statistically significant. In group B a positive difference was observed between final height (160.6 +/- 5.7 cm) and target height (157.6 +/- 5.9 cm) (ns); on the contrary, in groups A and C, final height was lower than target height (155.5 +/- 5.3 and 156.4 +/- 1.3 cm, respectively), but only in group C the difference was statistically significant (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D011629 Puberty, Precocious Development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations below the mean age at onset of PUBERTY in the population. This early maturation of the hypothalamic-pituitary-gonadal axis results in sexual precocity, elevated serum levels of GONADOTROPINS and GONADAL STEROID HORMONES such as ESTRADIOL and TESTOSTERONE. Familial Precocious Puberty,Idiopathic Sexual Precocity,Precocious Puberty,Precocious Puberty, Central,Precocious Puberty, Male Limited,Precocious Puberty, Male-Limited,Pubertas Praecox,Sexual Precocity,Testotoxicosis,Central Precocious Puberties,Central Precocious Puberty,Familial Precocious Puberties,Idiopathic Sexual Precocities,Male-Limited Precocious Puberties,Male-Limited Precocious Puberty,Praecox, Pubertas,Precocious Puberties,Precocious Puberties, Central,Precocious Puberties, Familial,Precocious Puberties, Male-Limited,Precocious Puberty, Familial,Precocities, Idiopathic Sexual,Precocities, Sexual,Precocity, Idiopathic Sexual,Precocity, Sexual,Puberties, Central Precocious,Puberties, Familial Precocious,Puberties, Male-Limited Precocious,Puberties, Precocious,Puberty, Central Precocious,Puberty, Familial Precocious,Puberty, Male-Limited Precocious,Sexual Precocities,Sexual Precocities, Idiopathic,Sexual Precocity, Idiopathic
D001827 Body Height The distance from the sole to the crown of the head with body standing on a flat surface and fully extended. Body Heights,Height, Body,Heights, Body
D002064 Buserelin A potent synthetic analog of GONADOTROPIN-RELEASING HORMONE with D-serine substitution at residue 6, glycine10 deletion, and other modifications. Bigonist,Buserelin Acetate,HOE-766,Profact,Receptal,Suprecur,Suprefact,Tiloryth,Acetate, Buserelin,HOE 766,HOE766
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D005640 Follicle Stimulating Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity. FSH (Follicle Stimulating Hormone),Follicle-Stimulating Hormone,Follitropin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations

Related Publications

F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
January 2018, PloS one,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
March 2023, Annals of pediatric endocrinology & metabolism,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
March 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
November 1994, Archives of pediatrics & adolescent medicine,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
May 2009, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
March 2020, Annals of pediatric endocrinology & metabolism,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
January 2002, Hormone research,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
April 2006, The Journal of clinical endocrinology and metabolism,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
January 2023, Scientific reports,
F Antoniazzi, and M Cisternino, and G Nizzoli, and M Bozzola, and A Corrias, and F De Luca, and C De Sanctis, and F Rigon, and G Zamboni, and S Bernasconi
July 2000, Journal of pediatric endocrinology & metabolism : JPEM,
Copied contents to your clipboard!